THE ASSESSMENT OF THE INFLUENCE OF WOMEN'S ATTITUDES ABOUT SCREENING BENEFITS AND MOTIVATIONAL FACTORS ON THEIR PARTICIPATION IN THE PAPANICOLAU SCREENING TEST

  • Vesna Jovanovic Academy for Applied Studies Belgrade, The College of Health Sciences, Belgrade, Serbia
  • Vesna Pazun Academy for Applied Studies Belgrade, The College of Health Sciences, Belgrade, Serbia
  • Vesna Maksimovic Academy for Applied Studies Belgrade, The College of Health Sciences, Belgrade, Serbia
  • Vesna Vukovic Academy for Applied Studies Belgrade, The College of Health Sciences, Belgrade, Serbia
Keywords: cervical cancer, Papanicolaou test, screening test, attitudes, motivation

Abstract


Introduction/Aim: In Serbia, cervical cancer (CC) is the second most common cancer, after breast cancer. The Papanicolaou test (PAP test) is used for the early detection of cervical cancer. Motivational factors and attitudes of women about the benefits of the Papanicolaou screening test can affect the rate of participation in it. The aim of the research was to examine whether there is a connection between women's attitudes about the benefits of screening and motivational factors and their participation in the Papanicolaou screening test of CC.

Methods: This cross-sectional study included 300 women aged 21 to 69, who came for a gynecological examination to the Gynecology and Obstetrics Clinic "Narodni Front" in Belgrade, in the period from June to December 2015. Data were collected from all respondents on their demographic characteristics, reason for coming to the clinic, how often they underwent screening (Papanicolaou test), as well as data on their attitudes about the benefits of screening and motivation for undergoing the Papanicolaou screening test using a part of the questionnaire called CPC -28 questionnaire (in Spanish, Creencias, Papanicolaou, Cancer -28).

Results: Of the 300 women who participated in the study, 37.3% of women regularly participated in the Papanicolaou test, 43.7% irregularly, and 19.0% never. Women who participated regularly in screening were significantly more likely to believe that it was important to have a regular Pap test to know they were healthy (F = 13.59; p˂0.001) and that the Pap test was the best way to determine early-stage CC (F = 12.29; p˂0.001) compared to women who were irregular and who had never participated in screening. Women who participated irregularly or who had never participated in the screening program would be motivated to participate in it significantly more often if someone developed CC in their family or environment (F = 5.11; p = 0.007), while women who regularly participated would be motivated significantly more often by gynecologist’s recommendations (F = 5.58; p = 0.004) and care for their own health (F = 6.93; p = 0.001). The high level of motivation was significantly related to the decision of women to regularly participate in screening (x2 = 13.05; p = 0.001) in relation to women who were irregular or who had never participated in screening.

Conclusion: Within this research, it was noticed that only every third respondent regularly underwent the Papanicolaou screening test, which is far lower than the set national goals that at least 75% of the target population of women aged 25 to 64 should be covered by organized screening. It is necessary to raise women's awareness about the importance of Papanicolaou screening for early detection of CC, as well as about all other preventive measures, and especially about the importance of the HPV vaccine.

References

The European Network of Cancer Registries ENCR,2016.

Oranratanaphan S, Amatyakul P, Iramaneerat K, Srithipayawan S. Knowledge, attitudes and practices about the Pap smear among medical workers in Naresuan University Hospital, Thailand. Asian Pac J Cancer Prev 2010; 11:1727-30.

The National Program of Organized Screening for Cervical Cancer. The National professional committee for the prevention and control of cervical cancer, 2013.

Matejić B, Vuković D, Pekmezović T, Kesić V, Marković M. Determinants of preventive health behavior in relation to cervical cancer screening among the female population of Belgrade. Health Educ Res 2011; 26(2):201-211.

Glanz K, Rimer BK, Lewis FM. Health behavior and health education: theory, research, and practice. (3rd ed) New Jersey: Jossey-Bass, 2002.

Muhammad Hoque, C M Ibekwe, Busi Ntuli-Ngcobo.Screening and Perceived Severity of Cervical Cancer amongWomen Attending Mahalapye District Hospital, Botswana. APJPH2009;10(6):1095-1100.

Urrutia MT, Araya A, Rivera S, Viviani P, Villarroel L. A predictive model for the quality of sexual life in hysterectomized women. Revista Médica de Chile 2007; 135(3):317-325.

Leyva M, Byrd T, Tarwater P. Attitudes towards cervical cancer screening: A study of beliefs among women in Mexico. CJHP 2006; 4(2):13-24.

Jirojwong S, Maclennan R, Manderson L. Health beliefs and Pap smears among Thai women in Brisbane, Australia. APJPH 2001; 13(1):20-23.

Holroyd E, Taylor Piliae R. E, Twinn SF. Investigating Hong Kong's Filipino domestic workers' healthcare behavior, knowledge, beliefs and attitudes towards cervical cancer and cervical screening. Women Health 2003; 38(1):69-82.

Moreland S, Engelman K, Greiner K. A, Mayo M. S. Papanicolaou testing among Native American and Hispanic populations. Ethnicity & Disease 2006; 16(1):223-227.

Byrel TL, Peterson SK, Chavez R. Cervical cancer screening beliefs among young Hispanic women. Prev Med 2004; 38:192-197.

Seow A, Wong ML, Smith WCS, Lee HP. Beliefs and attitudes as determinants of cervical cancer screening: a community-based study in Singapore. Prev Med1995; 24:134-41.

Fernandez Esquer M. E., Cardenas Turanza M. Cervical cancer screening among Latinas recently immigrated to the United States. Prev Med 2004; 38:529-535.

Taylor V. M, Jackson J. C, Tu S. P, Yasui Y, Schwartz S. M, Kuniyuki A. Cervical cancer screening among Chinese Americans. Cancer Detec Prev 2002; 26(2):139-145.

Eunice E. Lee, Fogg L, Menon U. Knowledge and Beliefs Related to Cervical Cancer and Screening Among Korean American WomenWest J Nurs Res 2008; 30(8): 960–974.

Armstrong N, Eborall H. Resistance through risk: Women and cervical cancer screening. Health Risk and Society 2005; 7(2):161-176.

Hakama M, Pokhrel A, Malila N, Hakulinen T. Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre-invasive phase. Int J Cancer 2015; 136: 928-935.

Published
2021/10/15
Section
ORIGINAL ARTICLE